Güsewell S - Search Results

1

Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment.

Diem S, Fässler M, Hasan Ali O, Siano M, Niederer R, Berner F, Roux GA, Ackermann CJ, Schmid S, Güsewell S, Früh M, Flatz L. Diem S, et al. Among authors: gusewell s. Cancer Manag Res. 2018 Nov 8;10:5537-5544. doi: 10.2147/CMAR.S179767. eCollection 2018. Cancer Manag Res. 2018. PMID: 30519101 Free PMC article.

2

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients.

Fässler M, Diem S, Mangana J, Hasan Ali O, Berner F, Bomze D, Ring S, Niederer R, Del Carmen Gil Cruz C, Pérez Shibayama CI, Krolik M, Siano M, Joerger M, Recher M, Risch L, Güsewell S, Risch M, Speiser DE, Ludewig B, Levesque MP, Dummer R, Flatz L. Fässler M, et al. Among authors: gusewell s. J Immunother Cancer. 2019 Feb 20;7(1):50. doi: 10.1186/s40425-019-0523-2. J Immunother Cancer. 2019. PMID: 30786924 Free PMC article. Clinical Trial.

3

Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open-label, non-inferiority trial.

Abt D, Müllhaupt G, Mordasini L, Güsewell S, Markart S, Zumstein V, Kessler TM, Schmid HP, Engeler DS, Hechelhammer L. Abt D, et al. Among authors: gusewell s. BJU Int. 2019 Jul;124(1):134-144. doi: 10.1111/bju.14632. Epub 2018 Dec 17. BJU Int. 2019. PMID: 30499637 Clinical Trial.

4

Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment.

Su E, S Fischer, R Demmer-Steingruber, Nigg S, Güsewell S, Albrich WC, Rothermundt C, Silzle T, Kahlert CR. Su E, et al. Among authors: gusewell s, s fischer. ESMO Open. 2022 Oct;7(5):100587. doi: 10.1016/j.esmoop.2022.100587. Epub 2022 Aug 24. ESMO Open. 2022. PMID: 36156449 Free PMC article.

5

Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial.

Abt D, Hechelhammer L, Müllhaupt G, Markart S, Güsewell S, Kessler TM, Schmid HP, Engeler DS, Mordasini L. Abt D, et al. Among authors: gusewell s. BMJ. 2018 Jun 19;361:k2338. doi: 10.1136/bmj.k2338. BMJ. 2018. PMID: 29921613 Free PMC article. Clinical Trial.

6

Outcome of older myeloma patients in relationship to comorbidities and availability of second-generation novel agents in a real-life setting.

Lalive d'Epinay M, Güsewell S, Graf N, Mey UJM, Driessen C, Hitz F. Lalive d'Epinay M, et al. Among authors: gusewell s. Hematol Oncol. 2022 Oct;40(4):716-723. doi: 10.1002/hon.3024. Epub 2022 May 22. Hematol Oncol. 2022. PMID: 35574642

7

Advanced non-contrasted computed tomography post-processing by CT-Calculometry (CT-CM) outperforms established predictors for the outcome of shock wave lithotripsy.

Langenauer J, Betschart P, Hechelhammer L, Güsewell S, Schmid HP, Engeler DS, Abt D, Zumstein V. Langenauer J, et al. Among authors: gusewell s. World J Urol. 2018 Dec;36(12):2073-2080. doi: 10.1007/s00345-018-2348-x. Epub 2018 May 29. World J Urol. 2018. PMID: 29845319

8

Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases.

Sawatzki M, Güller U, Güsewell S, Husarik DB, Semela D, Brand S. Sawatzki M, et al. Among authors: gusewell s. J Hepatol. 2021 Feb;74(2):419-427. doi: 10.1016/j.jhep.2020.09.036. Epub 2020 Oct 14. J Hepatol. 2021. PMID: 33065168

9

Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study.

Kohler PP, Kahlert CR, Sumer J, Flury D, Güsewell S, Leal-Neto OB, Notter J, Albrich WC, Babouee Flury B, McGeer A, Kuster S, Risch L, Schlegel M, Vernazza P. Kohler PP, et al. Among authors: gusewell s. Infect Control Hosp Epidemiol. 2021 May;42(5):604-608. doi: 10.1017/ice.2020.1244. Epub 2020 Oct 8. Infect Control Hosp Epidemiol. 2021. PMID: 33028454 Free PMC article.

10

Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland.

Moccia AA, Aeppli S, Güsewell S, Bargetzi M, Caspar C, Brülisauer D, Ebnöther M, Fehr M, Fischer N, Ghilardi G, Krasniqi F, Lang N, Mey U, Mingrone W, Novak U, Pfleger C, Richter P, Rütti M, Schmidt A, Stenner F, Voegeli M, Zander T, Zucca E, Hitz F. Moccia AA, et al. Among authors: gusewell s. Hematol Oncol. 2021 Apr;39(2):196-204. doi: 10.1002/hon.2830. Epub 2020 Dec 23. Hematol Oncol. 2021. PMID: 33300135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters